Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Microneedles can precisely deliver cancer treatments with fewer side effects.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Nivolumab can cause hair loss as a rare side effect.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.